ArticleAmerican journal of epidemiology2013
Point: cervical cancer screening guidelines should consider observational data on screening efficacy in older women.
Article in American journal of epidemiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Survival by Treatment Recommendation and Receipt Among Older Patients With Early-Stage Cervical Cancer.JAMA network open · 2025Article
- Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2024Article
- Expanding the upper age limit for cervical cancer screening: a protocol for a nationwide non-randomised intervention study.BMJ open · 2020Article
- Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting.International journal of cancer · 2020Article
- Nationwide cervical cancer screening in Korea: data from the National Health Insurance Service Cancer Screening Program and National Cancer Screening Program, 2009-2014.Journal of gynecologic oncology · 2017Article
- Influence of HIV/AIDS on Cervical Cancer: A Retrospective Study From Tanzania.Journal of global oncology · 2017Article
- Cervical cancer screening in older women: new evidence and knowledge gaps.PLoS medicine · 2014Article
- Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study.PLoS medicine · 2014Article
- Counterpoint: cervical cancer screening guidelines--approaching the golden age.American journal of epidemiology · 2013Article
Corrections and comments
- Commented on by
Authors and funding
3 authors.
Funding
Abstract
Recent guidelines from the American Cancer Society, the American Society for Colposcopy and Cervical Pathology, and the American Society for Clinical Pathology recommend cessation of cervical cancer screening at age 65 years for women with an "adequate" history of negative Papanicolaou smears. In our view, those who formulated these guidelines did not consider a growing body of evidence from nonrandomized studies that provides insight into the efficacy of cervical cancer screening among older women. First, older women are not at indefinitely low risk following negative screening results. Second, recent data from the United States, the United Kingdom, and Sweden suggest that screening of older women is associated with substantial reductions in cervical cancer incidence and mortality, even among previously screened women. It may be that after consideration of the reduced incidence of (and reduced mortality from) cervical cancer that may result from screening older women, the harms and economic costs of screening will be judged to outweigh its benefits. However, it is essential to consider the now-documented benefits of cervical screening when formulating screening guidelines for older women, and recommendations that do not do so will lack an evidence base.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.